• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1600060 Anifrolumab注射液 anifrolumab Injection Biological Products Import Drug Application 2016-11-10 Medimmune LLC Certificate Issued 2017-11-01 view
JXSL2400078 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Import Drug Application 2024-04-20 view
JXSL2300115 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Import Drug Application 2023-06-27 view
JXSB2400135 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Supplementary Application 2024-10-23 view
JXSB2400013 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Supplementary Application 2024-02-05 view
JXSL2300092 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Import Drug Application 2023-05-12 view
JXSB2400136 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Supplementary Application 2024-10-23 view
JXSL2300160 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Import Drug Application 2023-09-01 view
JXSL2101106 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Import Drug Application 2021-09-02 view
JTS2400098 Anifrolumab注射液 anifrolumab Injection Biological Products Disposable Import Drug Application 2024-09-21 view
JXSB2400061 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Supplementary Application 2024-05-28 view
JXSL2300135 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Import Drug Application 2023-07-22 view
JXSL2000211 Anifrolumab注射液 anifrolumab Injection Biological Products(1) Import Drug Application 2020-12-14 AstraZeneca AB AstraZeneca AB In Review 2020-12-03 view